Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity
The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
The sedative drug thalidomide ([+]-alpha-phthalimidoglutarimide), once abandoned for causing birth defects in humans, has found new therapeutic license in leprosy and other diseases, with renewed teratological consequences. Although the mechanism of teratogenesis and determinants of risk remain unclear, related teratogenic xenobiotics are bioactivated by embryonic prostaglandin H synthase (PHS) to a free-radical intermediates that produce reactive oxygen species (ROS), which cause oxidative damage to DNA and other cellular macromolecules. Similarly, thalidomide is bioactivated by horseradish peroxidase, and oxidizes DNA and glutathione, indicating free radical-mediated oxidative stress. Furthermore, thalidomide teratogenicity in rabbits is reduced by the PHS inhibitor acetylsalicylic acid, indicating PHS-catalyzed bioactivation. Here, we show in rabbits that thalidomide initiates embryonic DNA oxidation and teratogenicity, both of which are abolished by pre-treatment with the free radical spin trapping agent alpha-phenyl-N-t-butylnitrone (PBN). In contrast, in mice, a species resistant to thalidomide teratogenicity, thalidomide does not enhance DNA oxidation, even at a dose 300% higher than that used in rabbits, providing insight into an embryonic determinant of species-dependent susceptibility. In addition to their therapeutic implications, these results constitute direct evidence that the teratogenicity of thalidomide may involve free radical-mediated oxidative damage to em…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They may cause direct cytotoxicity by inducing free radical mediated DNA damage.80”
From Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management (2024) · cites this paper as [80]
Citations
Cites
8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions.
Cheng, K. C., Cahill, D. S., Kasai, H., Nishimura, S., & Loeb, L. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48474-8 · Cited by 1,844
A short history of thalidomide embryopathy
Lenz, W. (1988) · Teratology · doi:10.1002/tera.1420380303 · Cited by 784
Biochemical Toxicology of Chemical Teratogenesis
Wells, P. G., & Winn, L. M. (1996) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239609110574 · Cited by 160
Self-citationThalidomide teratogenesis: evidence for a toxic arene oxide metabolite.
Gordon, G., Spielberg, S. P., Blake, D. A., & Balasubramanian, V. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2545 · Cited by 153
Schumacher, H., Smith, R. L., & Williams, R. T. (1965) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1965.tb02054.x · Cited by 144
Winn, L. M., & Wells, P. G. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00340-1 · Cited by 129
Self-citationProposed mechanisms of action in thalidomide embryopathy
Stephens, T. D. (1988) · Teratology · doi:10.1002/tera.1420380307 · Cited by 111
Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity1
Winn, L. M., & Wells, P. G. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00193-2 · Cited by 102
Self-citationFree Radical Intermediates of Phenytoin and Related Teratogens
Parman, T., Chen, G., & Wells, P. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25079 · Cited by 93
Self-citationCharacterization of a novel cytochrome P450 from the transformable cell line, C3H/10T1/2
Pottenger, L. H., & Jefcoate, C. R. E. (1990) · Carcinogenesis · doi:10.1093/carcin/11.2.321 · Cited by 88
Research works printed but not linked: 1
- Arlen, R.R. & Wells, P.G. Extracellular thiol-disulfide status reflecting chemical toxicity mediated via oxidative stress: Validation with paraquat and t-butylhydroperoxide and implications for phenytoin and thalidomide teratogenicity. FASEB J. 4, A608 (1990).
Cited by
Items 301–400 of 535
Polymorphisms in the endothelial nitric oxide synthase gene in thalidomide embryopathy
Vianna, F. S. L., Fraga, L. R., Tovo‐Rodrigues, L., Tagliani‐Ribeiro, A., Biondi, F., Maximino, C. M., Sanseverino, M. T. V., Hutz, M. H., & Schüler‐Faccini, L. (2013) · Nitric Oxide · doi:10.1016/j.niox.2013.09.002 · Cited by 17
Therapeutic potential of thalidomide for gemcitabine-resistant bladder cancer
Huang, Y., CHENG, C. C., Chiu, T. H., & Lai, P. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3155 · Cited by 16
Miller‐Pinsler, L., Sharma, A. M., & Wells, P. G. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1482-0 · Cited by 16
Self-citationMilosevic, N., Bekhite, M. M., Sharifpanah, F., Ruhe, C., Wartenberg, M., & Sauer, H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3139 · Cited by 16
McCallum, G. P., Siu, M. T., Ondovcik, S. L., Sweeting, J. N., & Wells, P. G. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20701 · Cited by 16
Self-citationThalidomide: An Old Drug with New Clinical Applications
Baidas, S. M., Tfayli, A., & Bhargava, P. (2002) · Cancer Investigation · doi:10.1081/cnv-120002498 · Cited by 16
Fanindi, A., Sutjahjo, S. H., Aisyah, S. I., & Purwantari, N. D. (2019) · Tropical Animal Science Journal · doi:10.5398/tasj.2019.42.2.97 · Cited by 16
Miller‐Pinsler, L., & Wells, P. G. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.06.007 · Cited by 16
Self-citationRamkissoon, A., & Wells, P. G. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.010 · Cited by 16
Self-citationLu, H. P., Jia, Y. N., Yan, Y., & Xu, L. (2017) · International Journal of Food Properties · doi:10.1080/10942912.2017.1368554 · Cited by 16
Breakthroughs in the Management of Multiple Myeloma
Heffner, L. T., & Lonial, S. (2003) · Drugs · doi:10.2165/00003495-200363160-00001 · Cited by 16
McCallum, G. P., Siu, M. T., Sweeting, J. N., & Wells, P. G. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.10.004 · Cited by 15
Self-citationWells, P. G., McCallum, G. P., Miller, L., Siu, M. T., & Sweeting, J. N. (2013) · Wiley eBooks · doi:10.1002/9781118353110.ch7 · Cited by 15
Self-citationDFT study on addition reaction mechanism of guanine-cytosine base pair with OH radical
Li, M., Diao, L., Liao, X., Kou, L., & Lu, W. (2015) · Journal of Physical Organic Chemistry · doi:10.1002/poc.3434 · Cited by 15
Combe, B. G. (2001) · Joint Bone Spine · doi:10.1016/s1297-319x(01)00326-8 · Cited by 15
Assessment of the in vitro and in vivo genotoxicity of Thalomid� (thalidomide)
Teo, S. K., Morgan, M., Stirling, D., & Thomas, S. D. (2000) · Teratogenesis Carcinogenesis and Mutagenesis · doi:10.1002/1520-6866(2000)20:5<301::aid-tcm6>3.0.co;2-2 · Cited by 15
Thalidomide : mécanismes d'action et indications en hématologie
Leleu, X. P., Micol, J., Guièze, R., Berthon, C., Kuhnovsky, F., Terriou, L., Moreau, A., Yakoub‐Agha, I., Bauters, F., & Facon, T. T. F. (2004) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2004.06.017 · Cited by 15
Zamani, M., Katebi, M., Mehdizadeh, M., Kafami, L., & Soleimani, M. (2013) · PubMed Central · Cited by 14
Toxicologic pathology of the reproductive system
Wangikar, P. B., Ahmed, T., & Vangala, S. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-382032-7.10076-1 · Cited by 14
Drug Therapy in Pregnant and Nursing Women
Stika, C. S., & Frederiksen, M. C. (2007) · Elsevier eBooks · doi:10.1016/b978-012369417-1/50062-6 · Cited by 14
Treatment of relapsed and refractory myeloma
Reece, D. E., Leitch, H. A., Atkins, H. L., Voralia, M., Canning, L. A., LeBlanc, R., Belch, A. R., White, D. J., & Kovacs, M. J. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802064941 · Cited by 14
Miyata, M., Tamura, E., Motoki, K., Nagata, K., & Yamazoe, Y. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.4.469 · Cited by 14
Ergün, M. A., Konaç, E., Erbaş, D., & Ekmekçi, A. (2004) · Cell Biology International · doi:10.1016/j.cellbi.2003.12.005 · Cited by 14
Vinson, R. K., & Hales, B. F. (2001) · Teratology · doi:10.1002/tera.1083 · Cited by 14
Immunomodulation in myelodysplastic syndromes
Sekeres, M. A., & List, A. F. (2006) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2006.06.001 · Cited by 14
Bahado-Singh, R. O., Schenone, M., Cordoba, M. I., Shieh, W.-S., Maulik, D., Kruger, M. L., & Reece, E. A. (2011) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2010.529970 · Cited by 14
Post-Translational Regulation of AP-1 Transcription Factor DNA-Binding Activity in the Rat Conceptus
Ozolinš, T. R. S., & Hales, B. F. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23080-7 · Cited by 14
Blaschke, G., Meyring, M., Mühlenbrock, C., & Chankvetadze, B. (2002) · Il Farmaco · doi:10.1016/s0014-827x(02)01258-2 · Cited by 14
Fujita, K., Asami, Y., Murata, E., Akita, M., & Kaneko, K. (2002) · Okajimas Folia Anatomica Japonica · doi:10.2535/ofaj.79.101 · Cited by 14
Induction of tolerance for islet transplantation for type 1 diabetes
Seung, E., Mordes, J. P., Greiner, D. L., & Rossini, A. A. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0026-9 · Cited by 14
Immunomodulatory drugs in myelodysplastic syndromes
Galili, N., & Raza, A. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.7.805 · Cited by 14
Exploring Old Drugs for the Treatment of Hematological Malignancies
Gan, F., Cao, B., Wu, D., Chen, Z., Hou, T., & Mao, X. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795328427 · Cited by 13
NRF2 activation inhibits valproic acid-induced neural tube defects in mice
Piorczynski, T. B., Lapehn, S., Ringer, K. P., Allen, S. A., Johnson, G. A., Call, K., Lucas, S. M., Harris, C., & Hansen, J. M. (2021) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2021.107039 · Cited by 13
The Impact of Oxidative Stress on Female Reproduction and ART: An Evidence-Based Review
Gupta, S., Sekhon, L. H., Aziz, N., & Agarwal, A. K. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511547287.067 · Cited by 13
Teratology Studies in the Rabbit
Allais, L., & Reynaud, L. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-131-8_12 · Cited by 13
Conventional therapy and approach to management
Rajkumar, S. V., & Kyle, R. A. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2005.01.011 · Cited by 13
Zhu, Z. X., Fan, L. Y., & Wang, Q. (2011) · European Surgical Research · doi:10.1159/000323011 · Cited by 12
Thalidomide: Current Therapeutic Uses and Management of Its Toxicities
Tariman, J. D. (2003) · Clinical journal of oncology nursing · doi:10.1188/03.cjon.143-147 · Cited by 12
Larouche, G., & Hales, B. F. (2009) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20595 · Cited by 12
Genomic and in silico analyses of CRBN gene and thalidomide embryopathy in humans
Vianna, F. S. L., Kowalski, T. W., Tovo‐Rodrigues, L., Tagliani‐Ribeiro, A., de Godoy, B. A., Fraga, L. R., Sanseverino, M. T. V., Hutz, M. H., & Schüler‐Faccini, L. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.10.003 · Cited by 12
Kalter, H. (2003) · Elsevier eBooks · doi:10.1016/b978-044451364-9/50009-7 · Cited by 12
Zheng, S., Chang, W., Li, C., & Lou, H. (2016) · FEMS Yeast Research · doi:10.1093/femsyr/fow029 · Cited by 12
Tang, X., Yocum, D. E., Dejonghe, D., Nordensson, K., Lake, D. F., & Richard, J. W. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01888.x · Cited by 12
Treatment of myeloma: recent developments
Zweegman, S., & Huijgens, P. C. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200204000-00002 · Cited by 12
RPA1 protects DNA damage–induced PANoptosis in limb development
Yin, Q., Peng, S., Zhang, Z., Jiang, S., Li, X., Huang, D., Li, Y., Zhou, J. T., Xiao, J., Ye, L., et al. (2025) · Science Advances · doi:10.1126/sciadv.adw2756 · Cited by 11
Xu, H., Dang, S.-J., Cui, Y., Wu, Z., Zhang, J.-F., Mei, X., Feng, Y., & Li, Y.-Q. (2019) · Journal of Pain Research · doi:10.2147/jpr.s213112 · Cited by 11
Localized Fetomaternal Hyperglycemia: Spatial and Kinetic Definition by Positron Emission Tomography
Yao, J., Wang, C., Walsh, S. A., Hu, S., Sawatzke, A. B., Dang, D., Segar, J. L., Ponto, L. L. B., Sunderland, J. J., & Norris, A. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012027 · Cited by 11
Mannheim, D., Versari, D., Daghini, E., Gössl, M., Galili, O., Chade, A., Rajkumar, V. S., Ritman, E. L., Lerman, L. O., & Lerman, A. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01215.2006 · Cited by 11
Roles of Kupffer Cells in Alcoholic Liver Disease
Takei, Y., Arteel, G. E., Bergheim, I., Lambert, J. C., McMullen, M. R., Nagy, L. E., Enomoto, N., & Sato, N. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000168169.20591.64 · Cited by 11
Modulation of cereblon levels by anti-myeloma agents
Díaz-Rodríguez, E., & Pandiella, A. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1037752 · Cited by 11
Thalidomide: present and future in multiple myeloma
Hussein, M. A. (2005) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.5.1.25 · Cited by 11
Fraga, L. R., Diamond, A. J., & Vargesson, N. (2016) · Wiley eBooks · doi:10.1002/9780470015902.a0026052 · Cited by 11
Thalidomide-induced limb malformations: an update and reevaluation
Collins, M. D., & Scott, W. J. (2025) · Archives of Toxicology · doi:10.1007/s00204-024-03930-z · Cited by 10
Organizer formation in Hydra is disrupted by thalidomide treatment
Brooun, M., Manoukian, A. S., Shimizu, H., Bode, H. R., & McNeill, H. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.03.013 · Cited by 10
Prevention of Teratogenesis in Pregnancies of Obese Rats by Vitamin E Supplementation
Alcalá, M., Bolado‐García, V. E., Sánchez‐Vera, I., Clapés, S., Dasí, F., Sáez, G. T., Carrera, E., Álvarez-Gallego, F., Loeken, M. R., & Viana, M. (2021) · Antioxidants · doi:10.3390/antiox10081173 · Cited by 10
Plasma cell diseases and organ transplant: A comprehensive review
Cowan, A. J., Johnson, C. K., & Libby, E. N. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14731 · Cited by 10
Effect of thalidomide in different tumors in rodents
Palencia, G., Arrieta, O. G., Ríos, C., Altagracia, M., Kravzov, J., & Sotelo, J. (2002) · Journal of Experimental Therapeutics and Oncology · doi:10.1046/j.1359-4117.2002.01011.x · Cited by 10
Treatment of MDS: something old, something new, something borrowed…
Sekeres, M. A. (2009) · Hematology · doi:10.1182/asheducation-2009.1.656 · Cited by 10
Vargesson, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804239-7.00026-3 · Cited by 9
Kuwagata, M., Hasegawa, T., Takashima, H., Shimizu, M., Kitajima, S., & Yamazaki, H. (2021) · The Journal of Toxicological Sciences · doi:10.2131/jts.46.553 · Cited by 9
Reduced DNA oxidation in aged prostaglandin H synthase-1 knockout mice
Jeng, W., Ramkissoon, A., & Wells, P. G. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.016 · Cited by 9
Self-citationThalidomide induces apoptosis in undifferentiated human induced pluripotent stem cells
Tachikawa, S., Nishimura, T., Nakauchi, H., & Ohnuma, K. (2017) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-017-0192-8 · Cited by 9
Lee, C. J. J., Gonçalves, L. M. L., & Wells, P. G. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr084 · Cited by 9
Self-citationN OVEL B IOLOGICALLY B ASED T HERAPEUTIC S TRATEGIES IN M YELOMA
Gupta, D., Hideshima, T., & Anderson, K. C. (2002) · Reviews in Clinical and Experimental Hematology · doi:10.1046/j.1468-0734.2002.00082.x · Cited by 9
Thalidomide Effects in the Post-transplantation Setting in Patients with Multiple Myeloma
Santos, E. S., Goodman, M. S., BYRNES, J. J., & Fernandez, H. F. (2004) · Hematology · doi:10.1080/10245330310001652428 · Cited by 9
Novel therapies for multiple myeloma
Ryoo, J. J., Cole, C. E., & Anderson, K. C. (2002) · Blood Reviews · doi:10.1016/s0268-960x(02)00009-7 · Cited by 9
Loberg, L. I., Proctor, W. R., Burdick, A. D., Cauvin, A. J., DeLise, A. M., Hemkens, M. D., Hohlbaum, A. M., Hukkanen, R. R., Sedgwick, A., Shuey, D. L., et al. (2025) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2025.105793 · Cited by 8
Genetically induced redox stress occurs in a yeast model for Roberts syndrome
Mfarej, M. G., & Skibbens, R. V. (2021) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkab426 · Cited by 8
You, S. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00242 · Cited by 8
Tachikawa, S., Shimizu, M., Maruyama, K., & Ohnuma, K. (2018) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-018-0234-x · Cited by 8
Luzzio, F. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815675-9.00010-2 · Cited by 8
Toxicologic pathology of the reproductive system
Woldemeskel, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89773-0.00064-3 · Cited by 8
Multiple Myeloma and Related Disorders
Rajkumar, S. V., & Dispenzieri, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00101-8 · Cited by 8
Dar, P., Strassburger, D., Shaish, A., Levkovitz, H., Halperin, R., & Harats, D. (2001) · Gynecologic and Obstetric Investigation · doi:10.1159/000052934 · Cited by 8
Lenalidomide (Revlimid, CC-5013) in myelodysplastic syndromes: Is it any good?
Sekeres, M. A., & List, A. F. (2006) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-006-0012-9 · Cited by 8
Liu, J.-N., Chan, H. M., & Kubow, S. J. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.08.012 · Cited by 8
Arsenic trioxide as a treatment for myelodysplastic syndrome
Sekeres, M. A. (2006) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-006-0015-6 · Cited by 8
Laposa, R. R., Henderson, J. T., & Wells, P. G. (2003) · The FASEB Journal · doi:10.1096/fj.02-0689fje · Cited by 8
Self-citationWells, P. G. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0134-0 · Cited by 8
Self-citationLiu, N., Xie, Z., Li, H., & Wang, L. (2024) · Oncology Letters · doi:10.3892/ol.2024.14391 · Cited by 7
Role of inflammatory mediators in intracranial aneurysms: A review
Chen, C., Tang, F., Zhu, M., Wang, C., Zhou, H., Zhang, C., & Feng, Y. (2024) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2024.108329 · Cited by 7
In silico analysis of enantioselective binding of immunomodulatory imide drugs to cereblon
Murai, T., Kawashita, N., Tian, Y., & Takagi, T. (2016) · SpringerPlus · doi:10.1186/s40064-016-2761-9 · Cited by 7
Death and Rebirth of the Thalidomide Molecule: A Case of Thalidomide-Induced Sensory Neuropathy
Kesserwani, H. N. (2021) · Cureus · doi:10.7759/cureus.13140 · Cited by 7
Viewing teratogens through the lens of nicotinamide adenine dinucleotide ( NAD +)
Mark, P. R., & Dunwoodie, S. L. (2022) · Birth Defects Research · doi:10.1002/bdr2.2089 · Cited by 7
The Role of Drug Metabolism in Toxicity
Hanumegowda, U., & Davis, C. D. (2022) · Wiley eBooks · doi:10.1002/9781119851042.ch19 · Cited by 7
Habeos, G. I., Filippopoulou, F., Habeos, E. E., Kalaitzopoulou, E., Skipitari, M., Papadea, P., Lagoumintzis, G., Niarchos, A., Georgiou, C. D., & Chartoumpekis, D. V. (2022) · Antioxidants · doi:10.3390/antiox11112274 · Cited by 7
Cost–effectiveness of lenalidomide in multiple myeloma
Schey, S., & Higginson, I. J. (2010) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.10.19 · Cited by 7
DFT study of adenine‐uracil base pair damage by OH radical
Liao, X., Diao, L., Kou, L., Li, Z., Li, M., & Lu, W. (2015) · Journal of Physical Organic Chemistry · doi:10.1002/poc.3465 · Cited by 7
Oxidation of Guanosine Monophosphate with O2 via a Ru‐peroxo Complex in Water
Takenaka, M., Kikkawa, M., Matsumoto, T., Yatabe, T., Ando, T., Yoon, K., & Ogo, S. (2018) · Chemistry - An Asian Journal · doi:10.1002/asia.201801267 · Cited by 7
Neurodegeneration from Drugs and Aging‐Derived Free Radicals
Ramkissoon, A., Shapiro, A. M., Loniewska, M. M., & Wells, P. G. (2013) · Wiley eBooks · doi:10.1002/9781118355886.ch10 · Cited by 7
Self-citationLi, J., Qi, H., He, Z., Hu, W., Si, Z., & Li, Y. (2010) · European Surgical Research · doi:10.1159/000276989 · Cited by 7
Mechanisms of thalidomide teratogenicity
Günzler, V. (1999) · Nature Medicine · doi:10.1038/11273 · Cited by 7
Drug Therapy in Pregnant and Nursing Women
Stika, C. S., & Frederiksen, M. C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385471-1.00024-6 · Cited by 6
Ford, M. L., Wagener, M. E., Gangappa, S., Pearson, T. C., & Larsen, C. P. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01826.x · Cited by 6
Thalidomide Prevents Alcoholic Liver Injury in Rats Through Inhibition of Kupffer Cell Sensitization
Enomoto, N., Takei, Y., Hirose, M., Ikejima, K., Kitamura, T., & Sato, N. (2004) · Comparative Hepatology · doi:10.1186/1476-5926-2-s1-s37 · Cited by 6
Podhorecka, M., Halicka, H. D., Klimek, P., Kowal, M., & Dmoszyńska, A. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.09.023 · Cited by 6
Redox Redux: A Closer Look at Conceptal Low Molecular Weight Thiols
Rogers, J. M., & Hunter, E. S. (2001) · Toxicological Sciences · doi:10.1093/toxsci/62.1.1 · Cited by 6
Eicosanoids: the molecules of evolution
Lieb, J. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1274 · Cited by 6
Developmental toxicity of glyceryl trinitrate in quail embryos
Bardai, G. K., Hales, B. F., & Sunahara, G. I. (2011) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20801 · Cited by 6
Tolerance-inducing strategies in transplantation surgery?current status and perspectives
Fndrich, F., Ruhnke, M., Dresske, B., & Kremer, B. (2004) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-003-0415-1 · Cited by 6
Metadata
- Authors
- Parman, T., Wiley, M. J., & Wells, P. G.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Wells, Peter G.
- ORCID
- Wells, Peter G.
- Venue
- Nature Medicine
- Published
- 1999-05
- Volume
- 5
- Issue
- 5
- Pages
- 582-585
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- DOI
- 10.1038/8466
- OpenAlex
- W1568733499
- Semantic Scholar
- 584f5e94f837063f4ceb1b3ddec9c4c9c9ed44ff
- Cited by
- 495
- References
- 25
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 11 · 2023: 2 · 2022: 10 · 2021: 12 · 2020: 10 · 2019: 14 · 2018: 14 · 2017: 10 · 2016: 18 · 2015: 19 · 2014: 13 · 2013: 19 · 2012: 19
- FWCI
- 32.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- thalidomide, teratogenicity, oxidative DNA damage, free radicals, reactive oxygen species, prostaglandin H synthase, horseradish peroxidase, glutathione oxidation, spin trapping, aspirin, embryonic development, congenital malformations
- MeSH terms
- Animals, Cyclic N-Oxides, DNA Damage, Drug Resistance, Embryo, Mammalian, Female, Free Radicals, Hernia, Umbilical, Hypnotics and Sedatives, Nitrogen Oxides, Oxidation-Reduction, Pregnancy, Rabbits, Species Specificity, Teratogens, Thalidomide, Free Radical Scavengers, Limb Deformities, Congenital, Embryo Loss, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.